{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:55:48Z","timestamp":1781510148074,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.msard.2025.106910","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T23:27:34Z","timestamp":1765063654000},"page":"106910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-7697","authenticated-orcid":false,"given":"Guldeniz Cetin","family":"Erci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2623-1478","authenticated-orcid":false,"given":"Tugba Gencaga","family":"Atakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1179-1253","authenticated-orcid":false,"given":"Mesut","family":"Yigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4411-9253","authenticated-orcid":false,"given":"Ozlem","family":"Gulacti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-7546","authenticated-orcid":false,"given":"Sibel","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1196-4177","authenticated-orcid":false,"given":"Hasan Can","family":"Gudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-2260","authenticated-orcid":false,"given":"Damla Cetinkaya","family":"Tezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8667-9119","authenticated-orcid":false,"given":"Ipek Gungor","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-5141","authenticated-orcid":false,"given":"Serkan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106910_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103222","article-title":"Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease","volume":"56","author":"Akaishi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2025.106910_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032986","article-title":"Pediatric myelin oligodendrocyte glycoprotein antibody associated disease-Asymmetric papilledema and elevated ICP are two of the chameleons: a case report","volume":"102","author":"Alqahtani","year":"2023","journal-title":"Medicine"},{"issue":"13","key":"10.1016\/j.msard.2025.106910_bib0003","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0333102415570762","article-title":"Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension","volume":"35","author":"Alt\u0131okka-Uzun","year":"2015","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.msard.2025.106910_bib0004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase in the CNS of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.msard.2025.106910_bib0006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4103\/0028-3886.388051","article-title":"Anti-MOG antibody and idiopathic intracranial hypertension: is there a relation?","volume":"71","author":"Chakraborty","year":"2023","journal-title":"Neurol. India"},{"issue":"6","key":"10.1016\/j.msard.2025.106910_bib0007","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200020","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as intracranial hypertension: a case report","volume":"9","author":"Chaudhuri","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0b013e3182aabf11","article-title":"Epidemiology and risk factors for idiopathic intracranial hypertension","volume":"54","author":"Chen","year":"2014","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.msard.2025.106910_bib0009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"21","key":"10.1016\/j.msard.2025.106910_bib0010","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106910_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102829","article-title":"Idiopathic intracranial hypertension and multiple sclerosis","volume":"50","author":"Figueira","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2025.106910_bib0012","first-page":"S435","article-title":"Increased intracranial pressure on a patient with neuromyelitis optica spectrum disorder","volume":"12","author":"Forouzannia","year":"2021","journal-title":"Casp. J. Intern. Med."},{"issue":"13","key":"10.1016\/j.msard.2025.106910_bib0013","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106910_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejpn.2023.12.006","article-title":"Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"48","author":"Gericke","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.msard.2025.106910_bib0016","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2025.106910_bib0017","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"H\u00f6ftberger","year":"2015","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2025.106910_bib0018","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","article-title":"MOG antibody-associated optic neuritis","volume":"38","author":"Jeyakumar","year":"2024","journal-title":"Eye (L.)"},{"key":"10.1016\/j.msard.2025.106910_bib0019","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00701-021-04940-x","article-title":"Cerebrospinal fluid dynamics in idiopathic intracranial hypertension: a literature review and validation of contemporary findings","volume":"163","author":"Kaipainen","year":"2021","journal-title":"Acta Neurochir."},{"issue":"9","key":"10.1016\/j.msard.2025.106910_bib0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","article-title":"Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation","volume":"265","author":"Lotan","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106910_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578083","article-title":"Paediatric MOG-antibody disease presenting with intracranial hypertension and unilateral vision loss without radiological evidence of optic neuritis","volume":"378","author":"Maran","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.msard.2025.106910_bib0022","article-title":"New-onset headache and abnormal eye movements in a four-year-old child: indicators of increased intracranial pressure","volume":"14","author":"Miller","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.msard.2025.106910_bib0023","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106910_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578487","article-title":"Morales-briceno H. MOGAD presenting as fulminant intracranial hypertension","volume":"397","author":"Nagaratnam","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.msard.2025.106910_bib0025","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00415-020-10300-z","article-title":"Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder","volume":"268","author":"Netravathi","year":"2021","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0026","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200174","article-title":"Increased intracranial pressure in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"11","author":"Nguyen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0027","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/WNO.0000000000001000","article-title":"Idiopathic intracranial hypertension: glymphedema of the brain","volume":"41","author":"Nicholson","year":"2021","journal-title":"J. Neuroophthalmol."},{"issue":"15","key":"10.1016\/j.msard.2025.106910_bib0028","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.3390\/jcm13154468","article-title":"Isolated intracranial hypertensions as onset of myelin oligodendrocyte glycoprotein antibody disease","volume":"13","author":"Papetti","year":"2024","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.msard.2025.106910_bib0029","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1080\/00207454.2023.2273764","article-title":"Isolated intracranial hypertension without cerebral venous sinus thrombosis in APLA syndrome: an unique association","volume":"134","author":"Porey","year":"2024","journal-title":"Int. J. Neurosci."},{"issue":"4","key":"10.1016\/j.msard.2025.106910_bib0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0333102421997093","article-title":"Diagnosis and treatment of idiopathic intracranial hypertension","volume":"41","author":"Raoof","year":"2021","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.msard.2025.106910_bib0031","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0333102416650705","article-title":"Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension","volume":"37","author":"Samanc\u0131","year":"2017","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.msard.2025.106910_bib0032","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11916-023-01166-7","article-title":"Overlap and differences in migraine and idiopathic intracranial hypertension","volume":"27","author":"Sengupta","year":"2023","journal-title":"Curr. Pain Headache. Rep."},{"issue":"1","key":"10.1016\/j.msard.2025.106910_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12886-023-03280-x","article-title":"Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report","volume":"24","author":"Sorensen","year":"2024","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.msard.2025.106910_bib0034","article-title":"Atypical myelin oligodendrocyte glycoprotein antibody disease presenting with isolated elevated intracranial pressure","author":"Valdrighi","year":"2024","journal-title":"Neuroimmunol. Rep."},{"issue":"3","key":"10.1016\/j.msard.2025.106910_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0333102414534329","article-title":"Idiopathic intracranial hypertension","volume":"35","author":"Wakerley","year":"2015","journal-title":"Cephalalgia"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:46:18Z","timestamp":1781509578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S2211034825006480"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106910","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106910"}}